Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biologic Augmentation of TMJ Arthroscopy Using BMAC
Sponsor: Weill Medical College of Cornell University
Summary
The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to answer: Does BMAC injection reduce the amount of inflammation and structural damage in the TMJ? Researchers will compare BMAC injection to corticosteroid injections see if BMAC injection helps . Participants will : * Be randomized to receive either BMAC or CS injection during TMJ arthroscopy * Visit the clinic for 3 follow up visits over 6 months and answer questionnaires * have 2 MRIs of their jaw
Official title: Biologic Augmentation of Temporomandibular Joint Arthroscopy Using Bone Marrow Aspirate Concentrate (BMAC): A Proposed Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-04
Completion Date
2028-06
Last Updated
2026-04-17
Healthy Volunteers
No
Interventions
Bone Marrow Aspirate Concentrate
Single dose injection of bone marrow fluid from the participant's anterior iliac crest (hip) into the TMJ area during arthroscopy.
Corticosteroid (CS)
Single dose injection of cortiosteroid into the TMJ area during arthroscopy.
Locations (1)
Weill Cornell Medical College - NewYork-Presbyterian Hospital
New York, New York, United States